A study analysing Ustekinumab therapy in extraintestinal manifestations of Crohn's Disease
Latest Information Update: 06 Jul 2021
At a glance
- Drugs Ustekinumab (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- 06 Jul 2021 New trial record
- 23 May 2021 Results presented at the Digestive Disease Week 2021